Differential diagnosis of reactive arthritis in a patient with intravesical BCG immunotherapy by Aida Aguridă et al.
POSTER PRESENTATION Open Access
Differential diagnosis of reactive arthritis in a
patient with intravesical BCG immunotherapy
Aida Roxana Aguridă1*, Cristina Maria Sîrbu1, Alina Cristina Neguț1,2, Maria Magdalena Moțoi1,
Luminița Mariana Bradu1, Ramona Ștefania Popescu1,2, Andrei Nițulescu1, Anca Streinu-Cercel1,2,
Adrian Streinu-Cercel1,2
From The 10th Edition of the Scientific Days of the National Institute for Infectious Diseases “Prof Dr Matei
Bals”
Bucharest, Romania. 15-17 October 2014
Background
Intravesical administration of bacillus Calmette-Guerin,
a live attenuated strain of Mycobacterium bovis, is an
adjunctive therapy for superficial bladder cancer. While
generally well tolerated, both local and systemic compli-
cations may appear. The dose of BCG in instilations is
100 fold higher than a BCG vaccine.
Case report
We report the case of a 50 year-old female patient known
with bladder tumor operated in January 2014 followed by
4 weeks of intravesical BCG immunotherapy, one admin-
istration per week. After each course the patient accused
low grade fever, nausea, pollakiuria and hematuria with
limited duration. In March 2014, after a cystoscopy and a
bladder resection, she underwent another 5 weeks of
BCG instillations. After the fourth course the patient pre-
sented to our clinic for fever with chills, pollakiuria,
hematuria, conjunctivitis, myalgia and disabling migra-
tory arthritis of the left ankle and right knee.
Clinical exam at admission: high fever, left ankle and
right knee arthritis, impaired mobility in the left tem-
poromandibular joint. Following admission the patient
developed left metacarpophalangeal and proximal inter-
phalangeal arthritis of the index and medius. She had
leukocytosis with neutrophilia, reactive thrombocytosis
and high biologic inflammatory syndrome. Urinalysis
showed frequent leukocytes, no albuminuria and nega-
tive cultures.
The patient underwent arthrocentesis for synovial
fluid sampling; the smear showed absence of bacteria,
40% polymorphonuclear cells, 15% small lymphocytes,
20% medium lymphocytes, 25% large lymphocytes and
the Ziehl-Neelsen smear was negative. The culture for
Mycobacterium spp. was negative.
Suspecting a BCG arthritis and cystitis we started
empiric antituberculous (antiTB) and glucocorticoid
therapy. A week after admission Serratia marcescens
was identified in one blood culture out of three col-
lected, so we added ertapenem for 14 days.
Rheumatological examination raised suspicion of an
autoimmune illness, but all specific blood tests were
negative. Despite that, the rheumatologist added sulfasa-
lazine, considering that even BCG arthritis can associate
an autoimmune disorder. After 2 months of antiTB, glu-
cocorticoid and sulfasalazine treatment the evolution
was favorable, with remission of arthritis and fever.
Conclusion
In our case, the cause of arthritis could be the BCG
instillations, an autoimmune illness or the infection with
Serratia marcescens. While the long-term progression of
symptoms despite antiTB treatment is a strong argu-
ment in favor of an autoimmune cause (negative specific
tests being a counterargument), we cannot exclude the
immune disorder caused by BCG immunotherapy.
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